C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-2025340521-A1 · Nov 6, 2025 · US
[b, f]-condensed
[b, f]-condensed · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D281/16 |
| Official title | [b, f]-condensed |
| Display label | [b, f]-condensed |
| Total patents | 51 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2016 | 7 |
| 2017 | 8 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 7 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-12435047-B2 · Oct 7, 2025 · US
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
US-12059418-B2 · Aug 13, 2024 · US
Hepatitis b core protein modulators
US-2024025890-A1 · Jan 25, 2024 · US
Hepatitis b core protein modulators
US-11814376-B2 · Nov 14, 2023 · US
Inhibitors of the plasmodial surface anion channel as antimalarials
US-2023346797-A1 · Nov 2, 2023 · US
C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-2023303501-A1 · Sep 28, 2023 · US
C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-11649218-B2 · May 16, 2023 · US
Hepatitis b core protein modulators
US-2023044112-A1 · Feb 9, 2023 · US
Hepatitis b core protein allosteric modulators
US-2023019129-A1 · Jan 19, 2023 · US
Inhibitors of the plasmodial surface anion channel as antimalarials
US-2021121476-A1 · Apr 29, 2021 · US
C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-2021101872-A1 · Apr 8, 2021 · US
Hepatitis B core protein modulators
US-10968211-B2 · Apr 6, 2021 · US
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
US-2021085679-A1 · Mar 25, 2021 · US
Hepatitis B core protein allosteric modulators
US-10947224-B2 · Mar 16, 2021 · US
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
US-2021070703-A1 · Mar 11, 2021 · US
Inhibitors of the plasmodial surface anion channel as antimalarials
US-10881669-B2 · Jan 5, 2021 · US
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
US-10869865-B2 · Dec 22, 2020 · US
Carboxylic diarylthiazepineamines as mu-opioid receptor agonists
US-10844027-B2 · Nov 24, 2020 · US
Hepatitis B core protein modulators
US-10766890-B2 · Sep 8, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D281/16?
- CPC C07D281/16 is the Cooperative Patent Classification code for “[b, f]-condensed.”
- How many patents are filed under CPC C07D281/16 ([b, f]-condensed)?
- Our database includes 51 publications tagged with this CPC code.
- Is patent activity under CPC C07D281/16 growing?
- Publication counts under this code: 2 in 2024 vs 2 in 2025 (latest complete years).